NN Investment Partners Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

NN Investment Partners Holdings’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,118	Closed	-$635K	–	849
2021 Q1	$635K	Sell	14,118 -2,836	-17%	-$158K	﹤0.01%	692
2020 Q4	$958K	Buy	16,954 +2,719	+19%	+$135K	0.01%	647
2020 Q3	$676K	Buy	14,235 +354	+3%	+$19.7K	﹤0.01%	622
2020 Q2	$819K	Buy	+13,881	New	+$772K	0.01%	643
2016 Q3	–	Sell	-700	Closed	-$16K	–	880
2016 Q2	$16K	Hold	700	–	–	﹤0.01%	870
2016 Q1	$28K	Buy	+700	New	+$28.4K	﹤0.01%	840

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

NN Investment Partners Holdings's IONS Position: Q2 2021 in Review

NN Investment Partners Holdings sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 14,118 shares — an estimated $635K sold.

NN Investment Partners Holdings first reported a position in IONS in Q1 2016 and held it in 6 quarters. The position peaked at $958K in Q4 2020. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

NN Investment Partners Holdings reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
NN Investment Partners Holdings sold 14,118 Ionis Pharmaceuticals shares in Q2 2021, an estimated $635K.
NN Investment Partners Holdings first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 6 quarters.
NN Investment Partners Holdings's Ionis Pharmaceuticals position peaked at $958K in Q4 2020.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on NN Investment Partners Holdings's 13F filing for Q2 2021, filed 14 Jul 2021.